ExAblate® MRI-guided Focused Ultrasound is effective in reducing pain from bone metastases in patients who could not undergo radiation therapy
Patients reported significant improvement in well-being, function, and reduction in medication use
Thirty patients who suffer from medication-resistant tremor of Parkinson’s Disease will be treated in a randomized control trial and followed up for one year.
December 11, 2009
 
 
© © 2013 InSightec. All rights reserved

 CONTACT  I  PRIVACY POLICY   I

This site is brought to you by InSightec, developers of ExAblate® using MR guided Focused Ultrasound